Debra M. Bensen-Kennedy

Results from a randomized trial of salvage chemotherapy followed by lestaurtinib for patients with FLT3 mutant AML in first relapse

Mark J. Levis, Farhad Ravandi, Eunice S. Wang et al. · Blood · 2011 · 395 citations · Full text

Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor

Hilary Longhurst, Marco Cicardi, Timothy Craig et al. · New England Journal of Medicine · 2017 · 219 citations · Full text

Universal leukoreduction decreases the incidence of febrile nonhemolytic transfusion reactions to RBCs

Karen E. King, R. Sue Shirey, Sandra K. Thoman et al. · Transfusion · 2004 · 213 citations

Phase I trial of lestaurtinib for children with refractory neuroblastoma: a new approaches to neuroblastoma therapy consortium study

Jane E. Minturn, Audrey E. Evans, Judith G. Villablanca et al. · Cancer Chemotherapy and Pharmacology · 2011 · 98 citations

Neuro-oncology, Pediatric Neurosurgery, Refractory Neuroblastoma +5

Efficacy and safety of rVIII-SingleChain: results of a phase 1/3 multicenter clinical trial in severe hemophilia A

Johnny Mahlangu, Kazimierz Kuliczkowski, Faraizah Abdul Karim et al. · Blood · 2016 · 85 citations · Full text